Acceleron Pharma (XLRN) Misses Q4 EPS by 7c

Acceleron Pharma (NASDAQ: XLRN) reported Q4 EPS of ($0.75), $0.07 worse than the analyst estimate of ($0.68).

For earnings history and earnings-related data on Acceleron Pharma (XLRN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c